National Finalist 2002 Ernst & Young Entrepreneur Of The Year Award
Kauffman Supporter Of Entrepreneurship Award



























Medical Devices & Diagnostics
  Drug Discovery & Enabling Platform
Biotech, Biopharmaceuticals
  Healthcare Infrastructure & Services

PHOTOS
_____________________________

The d-Conference
_____________________________

30+ Speakers, 6 Panel Discussion, 2 Company Presentation Session, Networking Breaks, and a Private Cocktail Reception

The Biotech & Life Sciences Global Venture Congress™ d-conference is designed to explore the frontiers of biotech & life sciences, address the venture capital landscape, identify current trends in innovation, learn scientific discoveries and discover cutting-edge Biotech and Life Sciences companies.

Highlights
_____________________________

More than thirty distinguished speakers, six panel discussions, two innovative company presentation sessions, exclusive networking breaks, excellent food menu, premium wine/beer selections, and a private cocktail reception.

The Speakers
_____________________________

Speakers at the conference are world renowned visionaries, carefully chosen active investors in Biotech and Life Sciences companies, founders/C-level executives of cutting edge Biotech companies and renowned thought leaders, movers and shakers of the biotech industry and analysts. Click here to see confirmed speakers.

Speaker Bio in .pdf

Companies Seeking Funding
_____________________________

The Innovator Showcase is a presentation by a chosen few emerging Biotech and Life Sciences companies both private and public with "imminent funding" potential. The screening process is extremely rigorous and we will only select companies that we think are currently fundable.

For example Serenex and Transave, two 2005 conference presenters, were able to secure $30M and $17.824M, respectively.

Who Is Presenting: Examples of companies already chosen to present at the 2006 conference are:

  • 1) $57M funded drug discovery company seeking $40M Series C
  • 2) $30+M funded drug discovery company ready to go on Phase II and III clinical trials seeking $25M
  • 3) $9.2M funded cell therapeutics company approved for clinical trial seeking $6M
  • 4) Clinical Stage Pharmaceutical company, FDA approved for Phase II trial seeking $15M
  • 5) $2.1M funded Targeted drug company seeking $2.5M for Phase I and Initial Phase II
Apply for a company presentation now !

The Exhibitors
_____________________________

Exhibitors at the conference will be a chosen few: companies with cutting edge technologies, Biotech & Life Sciences products and services, international agencies, high profile Biotech and Life Science strategic partners and other service providers. Click here to see details and apply. You must have at least one executive registered for the conference to apply for exhibitor space.

Apply for a exhibitor table now !

The Delegates
Attendee Tips/FAQ By Attendees
_____________________________

Countries: Delegates already registered for 2006 Conference are from UK, Germany, Israel, Finland, Scotland, Canada, China and the USA.

d-Conference: Delegate-driven conference where the delegates submit issues for discussion by the panel speakers.

Privacy: For the privacy of our delegates, we don't give out the attendee list.

This d-conference (delegate-driven) will be a congregation of venture capitalists, corporate investors, strategic investors, angel investors, institutional investors, investment bankers, commercial bankers, biotech and life sciences company executives, entrepreneurs, analysts, thought leaders, scientists, researchers, academicians, and service providers. Before the conference, all registered delegates will be requested to submit issues for panel discussion. Past attendees include:

President & CEO- Serenex, Inc.; CEO-Transave, Inc.; President/CEO - Digital Bio (South Korea); CEO - Med Discovery (Switzerland); Director - Exgenis (UK); CEO - Congenix (Russia); Managing Director- The Carlyle Group; Professor Of Medicine- Columbia University; Partner - Phillips Nizer, LLP; Biotech Executive - Microsoft; President & CEO- BioTrove; President & COO- Pharmos Corporation; Principal- The Aurora Funds; Principal- Cannon Design; Principal- Bear Stearns Health Innoventures; Biotech Entrepreneur (M.D., Ph.D) - Harvard Medical School; Tech. Advisor & Patent Agent- Stroock & Stroock & Lavan; Sr. Vice President- Life Sciences Greenhouse; Sr. Vice President- William Gallagher Associates; VP of Research & Development/ CSO- Locus Pharmaceuticals, Inc; VP, Business Development- Chugai Pharma USA; Vice President- Cytel Inc.; and more...

Delegates Feedback
_____________________________

I was very impressed by the GVC event. To put this is perspective, I had just come from presenting at the DowJones VentureWire conference in San Francisco. I had anticipated that the DowJones event would be more valuable to --------, as I had little previous information about GVC. I was wrong. Overall, the GVC had much better panels and attracted a much larger number of leading venture capital firms and industry players. ----------

The conference represented two of the most productive days of my professional career..........

An exciting forum with effective information transferal. Not to be missed.....

Read More Here

Contacts:

Ms.Liliana Barreiro
Ms. Maysa Elmasri
Write to - gvcongress "at" saeclub.com

_____________________________

Program schedule, date, location and speakers are subject to change

 

2005 BioCongress

2004 BioCongress

From Past Conferences


(R) Nobel Laureate Dr. James Watson


(L) Nobel Laureate Dr. Ferid Murad


(L) Nobel Laureate Dr. Eric Chivian



 


| Venue | Accomodation | Contact | Cancellation Policy | Sponsorship Info | Speaker Info | Calendar | FAQ | SAEC Home |

Note: This conference is a self-paid, non-profit conference with a financial gurantee by the Chairman and SAEC founder


VC-Meet ™, Venture Congress ™ are trademarks of SAEC
©1999-2006 Silicon Alley Entrepreneurs Club (SAEC)
, SAEC Ventures, All rights reserved